Kyle Blackburn, M.D.

Kyle Blackburn, M.D.

  • Neurology
  • Antibody-Mediated Neurologic Disorders
  • Neurologic Complications of Cancers and Rheumatologic Disease

Biography

Kyle Blackburn, M.D., is an Assistant Professor in the Department of Neurology at UT Southwestern Medical Center. He specializes in neuroimmunology and has clinical interests in antibody-mediated neurologic disorders, including autoimmune encephalitis, epilepsy, and ataxias; neurologic complications of cancers, including paraneoplastic disorders and checkpoint inhibitor/CAR T-cell toxicity; and demyelinating disorders, including sarcoidosis, neuromyelitis optica, myelin oligodendrocyte glycoprotein (MOG)-associated disease, and multiple sclerosis. 

Dr. Blackburn earned his medical degree at the University of Kentucky College of Medicine. He performed his residency in adult neurology at UT Southwestern, serving his final year as Chief Resident, and stayed here to complete a fellowship in neuroimmunology, during which he earned the James T. Lubin Clinician Scientist Award from the Siegel Rare Neuroimmune Association (SRNA).

He joined the UT Southwestern faculty in 2020.

Education & Training
  • Medical School - University of Kentucky College of Medicine (2010-2014)
  • Fellowship - UT Southwestern Medical Center (2018-2020), Autoimmune Neurology
  • Residency - University of Texas Southwestern Medical School (2014-2018), Neurology
Professional Associations & Affiliations
  • American Academy of Neurology
Honors & Awards
  • Roger Rosenberg Fellow of the Year 2019, UT Southwestern
  • James T. Lubin Clinician Scientist Fellowship 2018, Siegel Rare Neuroimmune Association
  • AAN Enhanced Leadership Program 2018
  • Gold Humanism Honor Society, Inducted in 2013
Books & Publications
Research
  • Autoantibodies in Neurological Disorders
  • Autoimmune Encephalitis
  • Clinical Trials in Rare Neuroimmune Disorders
  • Multiple Sclerosis
  • Neuromyelitis Optica
  • Transverse Myelitis

Clinical Focus

  • Antibody-Mediated Neurologic Disorders
  • Neurologic Complications of Cancers and Rheumatologic Disease
  • Demyelinating Disorders

See More